BREAKING NEWS

Belgian Paralympian dies by euthanasia aged 40

Belgian Paralympian dies by euthanasia aged 40
FILE PHOTO: 2016 Rio Paralympics - Athletics - Women's 100m - T52 Final - Olympic Stadium - Rio de Janeiro, Brazil - 17/09/2016. Marieke Vervoort of Belgium celebrates with her bronze medal during the victory ceremony. REUTERS/Jason Cairnduff/File Photo -
Copyright
Jason Cairnduff(Reuters)
Euronews logo
Text size Aa Aa

BRUSSELS (Reuters) – Belgian Paralympian Marieke Vervoort died by euthanasia on Tuesday aged 40 after a battle with an incurable and degenerative spinal condition.

Vervoort, who won Paralympic gold in the 200 metres wheelchair race in the London Games in 2012, had signed euthanasia papers in 2008 in Belgium, where it is legal, and died in accordance with her wishes late on Tuesday.

Vervoort, who also won silver medals in London and at Rio in 2016, was diagnosed with the painful condition as a teenager and retired from competition after the Rio Games. She advocated dialogue on assisted dying in countries around the world.

The town of Diest in northern Belgium, where Vervoort was born, set up a book of condolence and carried a long message on its website about the woman it called “our Wielemie”, a reference to the wheels of her wheelchair.

“Despite her physical limitations she had a impressive sporting career,” the town said. “Marieke chose euthanasia a few years ago and followed through on her choice on Tuesday evening.”

Local poet Kristien Nys also penned some lines to the “silver-plated, gold-plated” Vervoort with an iron will and “angelic patience”. Vervoort’s smile would no longer be seen.

“But your pain is also gone, you have done your last lap, you have waited long enough, your big battle has been fought.”

(Reporting by Philip Blenkinsop; Editing by Alexandra Hudson)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.
Euronews is no longer accessible on Internet Explorer. This browser is not updated by Microsoft and does not support the last technical evolutions. We encourage you to use another browser, such as Edge, Safari, Google Chrome or Mozilla Firefox.